| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.3M | +20.2% |
| R&D Expense | $15.5M | -14.9% |
| SG&A Expense | $6.5M | -3.8% |
| Operating Income | -$14.7M | +22.2% |
| Net Income | -$14.1M | +25.0% |
| EPS (Basic) | -$3.87 | +29.1% |
| EPS (Diluted) | -$3.87 | +29.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | -46.2% |
| Accounts Receivable | $928K | -28.5% |
| Current Assets | $20.8M | -45.4% |
| Total Assets | $34.0M | -17.1% |
| Current Liabilities | $3.9M | -22.2% |
| Total Liabilities | $16.0M | +62.2% |
| Stockholders' Equity | $18.0M | -42.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +17.4% |
| Capital Expenditures | $676K | +686.0% |
| Investing Cash Flow | -$676K | -686.0% |
| Financing Cash Flow | $53K | -95.7% |
| Free Cash Flow | -$16.7M | +14.3% |